Search
for
Sort by
Research 31–60 of 1000+
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Melatonin Receptors and Their Role in Human Diseases
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Biological therapy in the treatment of melanoma
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Selective androgen receptor modulators: a critical appraisal
- RAGE and Its Ligands in Melanoma
- Signal integrator function of CXXC5 in Cancer
- A Case of Tricho-rhino-phalangeal Syndrome Caused by a Novel Heterozygous Nonsense Mutation in the TRPS1 Gene
- Life Sciences Discovery and Technology Highlights
- Recent advances in 3D bioprinting of tissues and organs for transplantation and drug screening
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Prostate cancer update: 2007
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Patched-assoziierte Tumoren: Modifikatorgene und Pathogenese
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Androgen antagonists in androgen target tissues
- Epigenetic regulation in adult stem cells and cancers
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment